The use of prazosin, an 1-adrenergic receptor blocker, showed that the ability of GLP-1RAs to reduce TNF- in plasma was disrupted, signifying the vital role of 1-adrenergic receptors in the anti-inflammatory action of GLP-1RAs
Oral GLP-1 options Oral formulations of GLP-1 medications are becoming more available and may offer different pricing dynamics
In humans gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) are the only known insulin stimulating incretin hormones and are released from intestinal cells after food intake 2,3,4,5
Cash-pay costs for GLP-1 medications can be high without coverage, and coverage varies widely by plan
Conversely, in some patients, reduced gastric emptying and prolonged retention of food in the stomach can also intensify reflux attacks due to the medications